Literature DB >> 19717281

Impact of interleukin-6 classic- and trans-signaling on liver damage and regeneration.

Claudia Drucker1, Jessica Gewiese, Sven Malchow, Jürgen Scheller, Stefan Rose-John.   

Abstract

Interleukin-6 (IL-6) has been suggested to play a pivotal role in liver regeneration. IL-6 on target cells activates a receptor complex consisting of the IL-6 receptor (IL-6R) and the signal transducing receptor subunit gp130. Not all cells in the body express the IL-6R on the cell surface. IL-6 can signal via two different pathways: classical signaling via the membrane bound IL-6R and IL-6 trans-signaling via a naturally occurring soluble IL-6R (sIL-6R). This second pathway widens the scope of IL-6 signaling since also cells expressing no membrane bound IL-6R can be stimulated by the trans-signal pathway. Mimicking IL-6 trans-signaling via a designer molecule, Hyper-IL-6 has been shown to accelerate liver regeneration. Another designer molecule, sgp130Fc, specifically blocks IL-6 trans-signaling. Using these proteins we investigated the contribution of IL-6 classic- and trans-signaling in the liver. Here we review the role of IL-6 signaling in response to liver damage and during liver regeneration. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19717281     DOI: 10.1016/j.jaut.2009.08.003

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  27 in total

1.  Hypoxic Conditioned Medium From Human Adipose-Derived Stem Cells Promotes Mouse Liver Regeneration Through JAK/STAT3 Signaling.

Authors:  Sang Chul Lee; Hye Jin Jeong; Sang Kuon Lee; Say-June Kim
Journal:  Stem Cells Transl Med       Date:  2016-04-21       Impact factor: 6.940

Review 2.  The autoimmune side of heart and lung diseases.

Authors:  Nancy Agmon-Levin; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

3.  IL-6 Contributes to Corneal Nerve Degeneration after Herpes Simplex Virus Type I Infection.

Authors:  Ana J Chucair-Elliott; Jeremy Jinkins; Meghan M Carr; Daniel J J Carr
Journal:  Am J Pathol       Date:  2016-08-03       Impact factor: 4.307

Review 4.  Towards identifying novel anti-Eimeria agents: trace elements, vitamins, and plant-based natural products.

Authors:  Frank Wunderlich; Saleh Al-Quraishy; Holger Steinbrenner; Helmut Sies; Mohamed A Dkhil
Journal:  Parasitol Res       Date:  2014-09-04       Impact factor: 2.289

5.  Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis.

Authors:  Weici Zhang; Masanobu Tsuda; Guo-Xiang Yang; Koichi Tsuneyama; Guanghua Rong; William M Ridgway; Aftab A Ansari; Richard A Flavell; Ross L Coppel; Zhe-Xiong Lian; M Eric Gershwin
Journal:  Hepatology       Date:  2010-07       Impact factor: 17.425

6.  Molecular characterization and expression analysis of the putative interleukin 6 receptor (IL-6Rα and glycoprotein-130) in rainbow trout (Oncorhynchus mykiss): salmonid IL-6Rα possesses a polymorphic N-terminal Ig domain with variable numbers of two repeats.

Authors:  Maria M Costa; Tiehui Wang; Milena M Monte; Christopher J Secombes
Journal:  Immunogenetics       Date:  2011-10-29       Impact factor: 2.846

7.  The Cholangiocyte Adenosine-IL-6 Axis Regulates Survival During Biliary Cirrhosis.

Authors:  Elise G Lavoie; Michel Fausther; Jessica R Goree; Jonathan A Dranoff
Journal:  Gene Expr       Date:  2017-09-11

8.  IL-6 regulates Mcl-1L expression through the JAK/PI3K/Akt/CREB signaling pathway in hepatocytes: implication of an anti-apoptotic role during liver regeneration.

Authors:  Chia-Hung Chou; Shuo-Lun Lai; Chiung-Nien Chen; Po-Huang Lee; Fu-Chuo Peng; Min-Liang Kuo; Hong-Shiee Lai
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

Review 9.  New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology.

Authors:  Maria D Giraldez; David Carneros; Christoph Garbers; Stefan Rose-John; Matilde Bustos
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-07-01       Impact factor: 46.802

10.  Interleukin-6 Trans-signaling: A Pathway With Therapeutic Potential for Diabetic Retinopathy.

Authors:  Shruti Sharma
Journal:  Front Physiol       Date:  2021-05-19       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.